Ozempic is a prescription medicine containing semaglutide that is primarily used with diet and exercise to improve blood sugar control in adults with type 2 diabetes. It may also reduce certain cardiovascular risks in eligible people with type 2 diabetes and established cardiovascular disease. Understanding its approved uses, eligibility.
Ozempic is the brand name for semaglutide, a medication belonging to a group called GLP 1 receptor agonists. It works by helping the body release insulin when blood glucose levels are elevated, reducing glucagon secretion, and slowing stomach emptying. These effects can help improve blood glucose control in people with type 2 diabetes. Medical professionals consider a person's health history, current medicines, blood glucose levels, and treatment goals before prescribing it.
Ozempic is approved for certain adults with type 2 diabetes and is generally used alongside diet and exercise. It is administered as a once weekly injection under the skin. Eligibility depends on individual medical circumstances rather than diabetes alone.
Common considerations include:
Adults diagnosed with type 2 diabetes may be considered for treatment.
It may be prescribed when additional blood glucose control is needed.
Certain adults with type 2 diabetes and established cardiovascular disease may use Ozempic to reduce the risk of major cardiovascular events, according to its approved indications.
Healthcare professionals consider other medicines and medical conditions before prescribing it.
Ozempic is not approved for treating type 1 diabetes.
It should not be used as a substitute for prescribed insulin in people who require insulin therapy.
Ozempic should not be confused with other semaglutide products that have different approved indications. For example, some semaglutide medicines are specifically approved for chronic weight management, while Ozempic's approved indications focus on type 2 diabetes and certain cardiovascular risk reduction.
Like other prescription medicines, Ozempic can cause side effects and may not be suitable for everyone. The most commonly reported effects involve the digestive system, particularly when treatment begins or the dose is increased. A healthcare professional can explain the potential benefits and risks based on an individual's circumstances.
Important safety considerations include:
Nausea, vomiting, diarrhea, abdominal pain, and constipation can occur.
Severe or persistent abdominal pain should receive prompt medical attention because it can be associated with pancreatitis.
Ozempic may contribute to dehydration when vomiting or diarrhea is significant.
People taking insulin or certain diabetes medicines may have an increased risk of low blood sugar.
Ozempic can affect stomach emptying and may influence the absorption of some oral medicines.
People with a history of diabetic retinopathy should discuss their condition with their healthcare professional.
Ozempic is contraindicated in people with a personal or family history of medullary thyroid carcinoma or with Multiple Endocrine Neoplasia syndrome type 2.
A healthcare professional should also know about pregnancy, planned pregnancy, allergies, previous pancreatic problems, gallbladder conditions, kidney problems, and all medicines or supplements being taken.
Ozempic should be used exactly as prescribed. Patients should not change the dose, stop treatment, or combine semaglutide products without medical advice.
Understanding Ozempic's approved uses and safety information can help people have informed discussions with their healthcare professionals. Because eligibility and risks vary between individuals, medical assessment is important before starting treatment. This information is educational and is not a substitute for personalized medical advice, diagnosis, or treatment.